(-0.04%) 5 243.25 points
(-0.01%) 39 557 points
(-0.11%) 18 276 points
(-0.01%) $79.11
(-0.80%) $2.36
(0.19%) $2 347.40
(0.34%) $28.54
(0.07%) $1 011.50
(0.09%) $0.927
(0.07%) $10.82
(0.27%) $0.798
(-0.21%) $91.40
Live Chart Being Loaded With Signals
Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services...
Stats | |
---|---|
Today's Volume | 1.19M |
Average Volume | 1.41M |
Market Cap | 7.42B |
EPS | HKD0 ( 2024-03-21 ) |
Last Dividend | HKD0.176 ( 2023-06-19 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 11.58 |
ATR14 | HKD0.00300 (0.05%) |
Volume Correlation
Tong Ren Tang Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Tong Ren Tang Correlation - Currency/Commodity
Tong Ren Tang Financials
Annual | 2023 |
Revenue: | HKD6.77B |
Gross Profit: | HKD2.85B (42.04 %) |
EPS: | HKD0.460 |
FY | 2023 |
Revenue: | HKD6.77B |
Gross Profit: | HKD2.85B (42.04 %) |
EPS: | HKD0.460 |
FY | 2022 |
Revenue: | HKD5.99B |
Gross Profit: | HKD2.59B (43.26 %) |
EPS: | HKD0.460 |
FY | 2021 |
Revenue: | HKD5.40B |
Gross Profit: | HKD2.29B (42.43 %) |
EPS: | HKD0.396 |
Financial Reports:
No articles found.
Tong Ren Tang Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.176 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0350 | 2001-04-11 |
Last Dividend | HKD0.176 | 2023-06-19 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 23 | -- |
Total Paid Out | HKD2.83 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.14 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.97 | |
Div. Directional Score | 8.04 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
6826.HK | Ex Dividend Knight | 2023-07-04 | Annually | 0 | 0.00% | |
1930.HK | Ex Dividend Junior | 2023-06-05 | Annually | 0 | 0.00% | |
0954.HK | No Dividend Player | 2023-05-22 | Sporadic | 0 | 0.00% | |
0064.HK | Ex Dividend Knight | 2023-08-29 | Semi-Annually | 0 | 0.00% | |
3315.HK | Ex Dividend Knight | 2023-05-30 | Annually | 0 | 0.00% | |
1522.HK | Ex Dividend Junior | 2023-06-29 | Sporadic | 0 | 0.00% | |
0563.HK | Ex Dividend Junior | 2023-05-24 | Sporadic | 0 | 0.00% | |
8635.HK | No Dividend Player | 2023-08-02 | Annually | 0 | 0.00% | |
2096.HK | Ex Dividend Junior | 2023-06-19 | Annually | 0 | 0.00% | |
1100.HK | Ex Dividend Knight | 2023-09-14 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0871 | 1.500 | 8.26 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0437 | 1.200 | 8.54 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0869 | 1.500 | -0.145 | -0.218 | [0.1 - 1] |
payoutRatioTTM | 0.371 | -1.000 | 6.29 | -6.29 | [0 - 1] |
currentRatioTTM | 4.49 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 2.29 | 0.800 | 1.237 | 0.990 | [0.8 - 2.5] |
cashRatioTTM | 1.227 | 1.500 | 4.30 | 6.44 | [0.2 - 2] |
debtRatioTTM | 0.120 | -1.500 | 7.99 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.541 | 2.00 | 9.82 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.450 | 2.00 | 9.78 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.236 | -1.500 | 9.06 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.420 | 1.000 | 6.33 | 6.33 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.165 | 1.000 | 8.70 | 8.70 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.426 | 1.000 | 8.75 | 8.75 | [0.2 - 2] |
assetTurnoverTTM | 0.501 | 0.800 | 9.99 | 7.99 | [0.5 - 2] |
Total Score | 11.12 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 11.76 | 1.000 | 8.91 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0869 | 2.50 | -0.0935 | -0.218 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.450 | 2.00 | 9.85 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.24 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.541 | 2.00 | 9.82 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.371 | 1.500 | 6.29 | -6.29 | [0 - 1] |
pegRatioTTM | -0.336 | 1.500 | -5.58 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.102 | 1.000 | 9.94 | 0 | [0.1 - 0.5] |
Total Score | 4.97 |
Tong Ren Tang
Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the technological development and sale of biological products, Chinese and Western medicines, cosmetics, and healthcare products; wholesale and retail sale of Chinese medicines and healthcare products; and internal and external surgery, medical examination, and hospital management activities. Further, it produces and processes biochemical products; extracts and processes plants; and produces food and daily chemical products, and medical services. The company was founded in 1669 and is based in Beijing, the People's Republic of China.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators